Notification Scheme News Today

The new MHRA scheme helps to reduce the time it takes for the lowest-risk clinical trials to commence, while maintaining patient safety.

As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, and compliance landscape. To help companies and...

Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.